Clinical Trial Update: Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating rivastigmine patch in mild to moderate Alzheimer's disease patients with coexisting cerebrovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cerebrovascular Disease

Drugs mentioned

• Rivastigmine Patch (Rivastigmine)

Snippet

Sponsor: National Neuroscience Institute | Conditions: Alzheimer Disease, CVA (Cerebrovascular Accident) | Phase 4 | Status: COMPLETED